Tiomate MDI (6+9) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Lupin Laboratories Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Formoterol Fumerate, Tiotropium Bromide. This drug comes in the form of Inhaler. The general packing available for this medicine consists of 180 mdi and is priced at Rs 398.09 (arround $5.57326 US Dollar)
Generic (Salt) Combination :
(Formoterol Fumerate+ Tiotropium Bromide)
Pharma Company :
Lupin Laboratories Ltd.
Brand Label :
Tiomate MDI (6+9)
Preparation Type :
Inhaler
Single Dose :
1 mdi
Composition (Fixed-Dose Combination) :
Formoterol Fumerate-6 mcg
Tiotropium Bromide-9 mcg
Pack Size/Qty/Vol :
180 mdi
Price Unit :
Rs 2.21 INR (arround $0.03094 US Dollar)
Price Pack :
Rs 398.09 INR (arround $5.57326 US Dollar)
Drug details for Tiomate MDI (6+9)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Tiomate MDI (6+9) are :
Formoterol Fumerate-6 mcg
Tiotropium Bromide-9 mcg
Formoterol Fumerate Indication (Prescribed for or used as):
For more details on Formoterol Fumerate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Formoterol Fumerate..
Tiotropium Bromide Indication (Prescribed for or used as): Chronic obstructive pulmonary disease (COPD).
For more details on Tiotropium Bromide, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Tiotropium Bromide..
Tiomate MDI (6+9) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 1 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Tiomate MDI (6+9), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Formoterol Fumerate-6 mcg Tiotropium Bromide-9 mcg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.